Table 1.
Demographic characteristics, baseline values and humoral immune response induced at T1 and T2 time-points by different vaccines in healthy adults and frail elderly individuals without any previously reported COVID-19 diagnosis.
| Comirnaty ≤65 | Comirnaty >65 | Spikevax ≤65 | Spikevax >65 | Vaxzevria≤ 65 | Vaxzevria >65 | Ad26.COV2.S≤65 | Ad26.COV2.S>65 | H V | |
|---|---|---|---|---|---|---|---|---|---|
| N=1401 | 587 | 228 | 273 | 56 | 140 | 33 | 28 | 18 | 38 |
| Median age (IQR) | 46 (35 - 54.5) | 71 (68 - 74) | 43 (31 - 48) | 71.5 (69 - 74.25) | 61 (51 - 63) | 68 (67 - 79) | 63 (62 - 64.25) | 68.5 (66.25 - 70) | 51 (44.25 - 54.75) |
| % Female | 55.37 | 46.49 | 59.71 | 39.29 | 57.14 | 51.52 | 67.86 | 50 | 42.11 |
| % T0 > 33.8 | 3.58 | 3.95 | 5.86 | 7.14 | 5.71 | 0 | 14.29 | 5.56 | 2.63 |
| % T1 > 33.8 | 99.83 | 96.93 | 100 | 89.29 | 98.57 | 100 | 89.29 | 77.78 | 100 |
| % T2 > 33.8 | 99.83 | 93.42 | 100 | 83.93 | 91.43 | 96.97 | 67.86 | 66.67 | 100 |
| GMT T0 (Range) | 5.51 (4.81 - 315) | 5.81 (4.81 - 1020) | 6.24 (4.81 - 596) | 7.05 (4.81 - 212) | 5.96 (4.81 - 822) | 5.04 (4.81 - 23) | 7.65 (4.81 - 195) | 5.73 (4.81 - 111) | 5.34 (4.81 - 47.1) |
| GMT T1 (Range) | 2120 (16.6 - 24900) | 1040.1 (4.81 - 35300) | 3777.1 (49.7 - 40100) | 1084.47 (4.81 - 41000) | 477.34 (17.1 - 3730) | 658.66 (47.5 - 6780) | 152.07 (19.2 - 13600) | 77.56 (25.1 - 1030) | 2566.02 (273 - 12800) |
| GMT T2 (range) | 495.1 (33.2 - 20500) | 268.66 (4.81 - 29400) | 1084.92 (48.4 - 21100) | 257.94 (4.81 - 22300) | 189.17 (10.9 - 2310) | 222.21 (29 - 5280) | 115.8 (10.7 - 4370) | 72.36 (7.77 - 3680) | 820.87 (181 - 2580) |